Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares · FLSC

Exhibit 99.1 INDEX TO FINANCIAL STATEMENT PAGE Audited Financial Statement of Frazier Life Sciences Acquisition Corp. II: Report of Independent Registered Public Accounting Firm (PCAOB #199) F-2 Balance Sheet as of October 15, 2026 F-3 Notes to Financial Statement F-4 Rep…

8-K · 2026-10-22 · 0001193125-26-429129

EXHIBIT 99.1 AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G The undersigned agree to file jointly with the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D or Schedule 13G or Forms 3, 4 or 5 (and any amendments or supplements thereto) required under sections 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the securities of any issuer. For that purpose, the undersig…

SCHEDULE 13G · 2026-10-16 · 0001104659-26-116496

Exhibit 99.1 Frazier Life Sciences Acquisition Corp. II Announces Pricing of $75,000,000 Initial Public Offering Palo Alto, CA, October 13, 2026 - Frazier Life Sciences Acquisition Corp. II (the “Company”), a special purpose acquisition company, announced today that it priced its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share. The Class A ordinary shares will be listed on The Nasdaq Capital Market and trade under the ticker symbol “FLSC” beginning o…

8-K · 2026-10-15 · 0001193125-26-422919

Exhibit 99.2 Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering Palo Alto, CA, October 15, 2026 - Frazier Life Sciences Acquisition Corp. II (the “Company”), a special purpose acquisition company, announced today the closing of its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share. The Class A ordinary shares are listed on The Nasdaq Capital Market and began trading under the ticker symbol “FLSC” as o…

8-K · 2026-10-15 · 0001193125-26-422919

Exhibit 10.7 PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT THIS PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT, dated as of, 2026, (as it may from time to time be amended, this “Agreement”), is entered into by and between Frazier Life Sciences Acquisition Corp. II, a Cayman Islands exempted company (the “Company”), and Frazier Life Sciences Holdings II, LLC, a Cayman Islands limited liability company (the “Purchaser”). WHEREAS, the Company intends to consummate an initial public offering (the “Pub…

S-1 · 2026-09-24 · 0001193125-26-399703

Exhibit 4.1 NUMBER NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP [•] FRAZIER LIFE SCIENCES ACQUISITION CORP. II INCORPORATED UNDER THE LAWS OF THE CAYMAN ISLANDS CLASS A ORDINARY SHARES This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE CLASS A ORDINARY SHARES OF THE PAR VALUE OF US$0.0001 EACH FRAZIER LIFE SCIENCES ACQUISITION CORP. II (THE “COMPANY”) Subject to the Company’s amended and restate…

S-1 · 2026-09-24 · 0001193125-26-399703